1H NMR visible lipids are induced by phosphonium salts and 5‐fluorouracil in human breast cancer cells

Cationic lipophilic phosphonium salts (CLPS) selectively accumulate in the mitochondria of neoplastic cells and inhibit mitochondrial function. The effects of the CLPS p‐(triphenylphosphoniummethyl) benzaldehyde chloride (drug A), and [4‐(hydrazinocarboxy)‐1‐butyl] tris‐(4‐dimethylaminophenyl) phosphonium chloride (drug B), on human breast cells of differing biological properties were assessed using growth inhibition assays and 1H NMR. Drug A and, to a lesser extent, drug B demonstrated selective growth inhibition of the highly tumorigenic DU4475 breast carcinoma cell line compared to the transformed HBL‐100 human breast cell line. However, in contrast to previous studies using other cell lines, no synergistic activity was found when the drugs were used in combination. 1H NMR demonstrated significant increases in mobile lipid acyl chain resonances in both cell lines treated with cytotoxic doses (IC50, 48 h) of the drugs used either alone or in combination. Two‐dimensional NMR revealed accompanying decreases in phosphocholine/Lys levels in HBL‐100 cells treated with A, B, or a 1:1 combination A+B at the IC50, and in DU4475 cells treated with drug A (IC50). This was accompanied by significant increases in cho/Lys ratios with IC50 A or combination A+B treatment. Similar spectra were observed in cells treated with 5‐fluorouracil but not methotrexate, indicating that mobile lipid accumulation is a general but not universal response to cytotoxic insult. Magn Reson Med 45:1001–1010, 2001. © 2001 Wiley‐Liss, Inc.

[1]  C. Mountford,et al.  Modulation of MR‐visible mobile lipid levels by cell culture conditions and correlations with chemotactic response , 1996, International journal of cancer.

[2]  J. Modica-Napolitano,et al.  Selective damage to carcinoma mitochondria by the rhodacyanine MKT-077. , 1996, Cancer research.

[3]  T. Calogeropoulou,et al.  Synergism through direct covalent bonding between agents: A strategy for rational design of chemotherapeutic combinations , 1990, Biopolymers.

[4]  T. Lampidis,et al.  Mitochondrial and plasma membrane potentials cause unusual accumulation and retention of rhodamine 123 by human breast adenocarcinoma-derived MCF-7 cells. , 1985, The Journal of biological chemistry.

[5]  C. Mountford,et al.  Lipid domain in cancer cell plasma membrane shown by 1H NMR to be similar to a lipoprotein , 1985, FEBS letters.

[6]  C. Mountford,et al.  Identification of triglyceride in malignant cells , 1991 .

[7]  N.m.r. studies of phospholipid metabolism and cell proliferation. , 1991, Biochemical Society transactions.

[8]  P. Wright,et al.  Assignment of acyl chain resonances from membranes of mammalian cells by two-dimensional NMR methods. , 1984, Biochemistry.

[9]  D. Rideout,et al.  Phosphonium salts exhibiting selective anti-carcinoma activity in vitro. , 1989, Anti-cancer drug design.

[10]  D. Rideout,et al.  Induction of magnetic resonance‐visible lipid in a transformed human breast cell line by tetraphenylphosphonium chloride , 1997, International journal of cancer.

[11]  R. Salem,et al.  Dequalinium, a topical antimicrobial agent, displays anticarcinoma activity based on selective mitochondrial accumulation. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[12]  P. Matarrese,et al.  1H‐MRS lipid signal modulation and morphological and ultrastructural changes related to tumor cell proliferation , 1999, Magnetic resonance in medicine.

[13]  W. Thilly,et al.  Quantitative differential effects of rhodamine 123 on normal cells and human colon cancer cells by magnetic resonance spectroscopy. , 1993, Cancer research.

[14]  J. Cohen,et al.  Magnetic resonance spectroscopy of tumors and potential in vivo clinical applications: a review. , 1989, Cancer research.

[15]  T. Lampidis,et al.  Selective killing of carcinoma cells "in vitro" by lipophilic-cationic compounds: a cellular basis. , 1985, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[16]  T. Jeitner,et al.  The accumulation of H-1 MR-visible lipid in human glioma cells is independent of the cell cycle. , 1997, International journal of oncology.

[17]  H. Thielmann,et al.  31P NMR studies of cultured human tumor cells. Influence of ph on phospholipid metabolite levels and the detection of cytidine 5′‐diphosphate choline , 1990, NMR in biomedicine.

[18]  M. Leach,et al.  The phosphocholine and glycerophosphocholine content of an oestrogen-sensitive rat mammary tumour correlates strongly with growth rate. , 1991, British Journal of Cancer.

[19]  D. Rideout,et al.  Mechanism of inhibition of fadu hypopharyngeal carcinoma cell growth by tetraphenylphosphonium chloride , 1994, International journal of cancer.

[20]  T. Lampidis,et al.  Anticarcinoma activity in vivo of rhodamine 123, a mitochondrial-specific dye. , 1983, Science.

[21]  L. B. Chen,et al.  Mitochondrial membrane potential in living cells. , 1988, Annual review of cell biology.

[22]  Thomas L Chenevert,et al.  Magnetic Resonance Imaging and Spectroscopy: Application to Experimental Neuro-Oncology. , 1994, Quarterly of magnetic resonance in biology and medicine.

[23]  K. Brindle,et al.  The appearance of neutral lipid signals in the 1H NMR spectra of a myeloma cell line correlates with the induced formation of cytoplasmic lipid droplets , 1993, Magnetic resonance in medicine.

[24]  F. Blankenberg,et al.  Quantitative analysis of apoptotic cell death using proton nuclear magnetic resonance spectroscopy. , 1997, Blood.

[25]  J. Modica-Napolitano,et al.  In vivo administration of MKT-077 causes partial yet reversible impairment of mitochondrial function. , 1996, Cancer research.

[26]  C. Mountford,et al.  Tetraphenylphosphonium chloride induced mr‐visible lipid accumulation in a malignant human breast cell line , 1996, International journal of cancer.

[27]  M. Melamed,et al.  Rhodamine 123 alters the mitochondrial ultrastructure of cultured L1210 cells. , 1985, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[28]  M. Melamed,et al.  Anticarcinoma activity of rhodamine 123 against a murine renal adenocarcinoma. , 1988, Cancer research.

[29]  G. Siuzdak,et al.  Cationic drug analysis using matrix-assisted laser desorption/ionization mass spectrometry: application to influx kinetics, multidrug resistance, and intracellular chemical change. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[30]  L. Le Moyec,et al.  Proton nuclear magnetic resonance spectroscopy reveals cellular lipids involved in resistance to adriamycin and taxol by the K562 leukemia cell line. , 1996, Cancer research.

[31]  I Barba,et al.  The relationship between nuclear magnetic resonance-visible lipids, lipid droplets, and cell proliferation in cultured C6 cells. , 1999, Cancer research.

[32]  P E Wright,et al.  Assignment of methylene proton resonances in NMR spectra of embryonic and transformed cells to plasma membrane triglyceride. , 1986, The Journal of biological chemistry.

[33]  Shishido,et al.  MKT-077, a novel rhodacyanine dye in clinical trials, exhibits anticarcinoma activity in preclinical studies based on selective mitochondrial accumulation. , 1996, Cancer research.

[34]  T. Brown,et al.  Phospholipid metabolites in 1H-decoupled 31P MRS in vivo in human cancer: implications for experimental models and clinical studies. , 1996, Anticancer research.

[35]  Risto A. Kauppinen,et al.  1H MRS detects polyunsaturated fatty acid accumulation during gene therapy of glioma: Implications for the in vivo detection of apoptosis , 1999, Nature Medicine.